New Molecule Could End Celiac Diet Restrictions

For the 300 million people worldwide living with celiac disease, a single crumb of bread can trigger painful inflammation and intestinal damage. Now, researchers in Barcelona have designed a molecule that could finally offer relief beyond complete dietary restriction.

Scientists at the University of Barcelona and the Spanish National Research Council created "celiacase," a molecule engineered to destroy gluten's toxic fragments right where digestion begins. The breakthrough addresses a problem that has stumped researchers for years: creating something that works in the highly acidic environment of the stomach.

The molecule tackles the 33-mer, one of gluten's most stubborn and harmful fragments. This peptide survives stomach acid and reaches the small intestine intact, where it triggers the autoimmune response that damages celiac patients. Celiacase breaks it down before it gets that far.

The team built on earlier work with nephrosin, a digestive molecule found in carnivorous pitcher plants. Through molecular engineering, they redesigned it to work at peak efficiency at pH 2, matching the stomach's natural acidity. Previous gluten-degrading supplements required much higher doses and worked poorly at stomach pH, making them ineffective alternatives to gluten-free diets.

Testing in mice showed dramatic results. Even when researchers fed high levels of gluten to mice with celiac disease, low doses of celiacase reduced intestinal damage, inflammation, and antibody responses. The treatment also restored healthy gut bacteria and immune markers to normal levels.

Professor Francisco José Pérez-Cano notes that the molecule stops working once it leaves the stomach and enters the duodenum. This built-in safety feature means it completes its job without interfering with other proteins the body needs.

Why This Inspires

This isn't just about making life more convenient for people with celiac disease. It's about freedom and dignity. Parents could stop worrying about contamination at birthday parties. Travelers could eat without fear in foreign countries. The constant vigilance that defines celiac life could finally ease.

The research team has already patented their discovery and is taking steps to create a company that will develop celiacase into a treatment. While more testing is needed before it reaches pharmacy shelves, the molecule's effectiveness at such low doses makes it a viable candidate for real-world use.

After decades of being told "just avoid gluten," millions may soon have an ally working on their behalf from the first bite.